AwesomeCapital
Search This Blog
Tuesday, September 10, 2019
Novavax target cut to $13 from $25 by Oppenheimer
Maintains Outperform
https://www.benzinga.com/stock/NVAX/ratings
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.